33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and safety of brexucabtagene autoleucel for relapsed/refractory B-cell acute lymphoblastic leukemia in patients aged 60 and above
    Meeting Abstract

    Muhsen, I.; Advani, A. S.; Roloff, G. W.; Jeyakumar, N.; Miller, K.; Zhang, A.; Sutherland, K. C.; Grunwald, M. R.; Kota, V. K.; Boccucci, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • NANO-LM: An updated scorecard for the clinical assessment of patients with leptomeningeal metastases
    Meeting Abstract

    Le Rhun, E.; Nayak, L.; Fat, M. J. L.; Rudà, R.; Pentsova, E.; Forsyth, P.; O'Brien, B.; Preusser, M.; Kumthekar, P.; Brandsma, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Dual-vector-transduction with single-step magnetic selection (Zip-sort) increases transgenic payloads to enhance CAR T cell activity
    Meeting Abstract

    James, S. E.; Chen, S.; Ng, B.; Fischman, J.; Jahn, L.; Boardman, A. P.; Rajagopalan, A.; Elias, H. K.; Massa, A. R.; Manuele, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Outcomes of patients with IDH1/2 mutated accelerated/blast-phase myeloproliferative neoplasms in the era of IDH inhibitors
    Meeting Abstract

    Goldberg, L. A.; Yoon, J. J.; Johnston, H.; Davidson, M. B.; Siddon, A.; Shallis, R. M.; Chen, E. C.; Burkart, M.; Oh, T. S.; Iyer, S. G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • TroFuse-015: A phase III study of trophoblast antigen 2 (TROP2)—directed antibody-drug conjugate sacituzumab tirumotecan (sac-TMT) vs treatment of physician's choice (TPC) for previously treated metastatic gastroesophageal adenocarcinoma (GEA)
    Meeting Abstract

    Shitara, K.; Wainberg, Z. A.; van Cutsem, E.; Janjigian, Y. Y.; Xu, R. H.; Oh, D. Y.; Xu, J.; Wu, S.; Bhaumik, S.; Bhagia, P.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • 292P Avelumab + axitinib (A + Ax) vs sunitinib (S) in patients (pts) with advanced renal cell carcinoma (aRCC): Subgroup analyses by age from the final analysis of the phase III JAVELIN Renal 101 trial
    Meeting Abstract

    Oya, M.; Motzer, R. J.; Choueiri, T. K.; Haanen, J. B. A. G.; Eto, M.; Uemura, H.; Venugopal, B.; Rini, B. I.; Miyake, H.; Albiges, L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Topical steroids for the prevention of radiation dermatitis in breast cancer: A systematic review and network meta-analyses of randomised controlled trials
    Meeting Abstract

    Tse, S. W.; Gojesvic, M.; Lee, S. F.; Caini, S.; Sauder, M.; Hircock, C.; Wang, A.; Chan, W.; Corbin, K.; Choi, I.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • 280P Efficacy of avelumab + axitinib (A + Ax) vs sunitinib (S) by number of IMDC risk factors in patients (pts) with advanced renal cell carcinoma (aRCC): Subgroup analyses from the final analysis of the phase III JAVELIN renal 101 trial
    Meeting Abstract

    Eto, M.; Motzer, R. J.; Choueiri, T. K.; Haanen, J. B. A. G.; Oya, M.; Uemura, H.; Venugopal, B.; Rini, B. I.; Miyake, H.; Albiges, L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A phase Ib/II open-label study evaluating trastuzumab deruxtecan (T-DXd) in combination with rilvegostomig and chemotherapy in patients with HER2-positive (HER2+) and HER2-low gastric or gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03 Part 4
    Meeting Abstract

    Janjigian, Y. Y.; Lloyd, C.; de Giorgio-Miller, V. G.; Chang, Y. T.; Lee, J.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Five-year overall survival (OS) and OS by baseline liver function from the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)
    Meeting Abstract

    Kudo, M.; Rimassa, L.; Chan, S. L.; Sangro, B.; Lau, G.; Breder, V. V.; Varela, M.; Crysler, O. V.; Bouattour, M.; Dao, V. T.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save